Q-omics provides the consensus-scored TUBB7P profile across patient tissues and cancer cell-line models. TUBB7P expression is associated with patient survival in 19 of 34 cancer types, with the highest sampling consensus in ACC. Among the 18 cancer types available for tumor–normal comparison, TUBB7P is differentially expressed in 10, with the highest sampling consensus in STAD. Additionally, TUBB7P RNA expression shows 11,244 significant gene co-expression associations, with the highest sampling consensus in TGCT. Together, these results highlight ACC, STAD, and TGCT as cancer lineages where TUBB7P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for TUBB7P — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes TUBB7P survival associations across molecular data types. TUBB7P RNA expression shows survival associations in the most cancer types (19), followed by mutation status (4). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible TUBB7P RNA expression–survival associations across cancer types. High TUBB7P expression shows unfavorable associations in ACC, LUAD, UCS, LGG, KICH and PCPG. The ACC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify ACC as the clearest survival context for TUBB7P RNA expression.
This table summarizes TUBB7P tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 10. The strongest signals are observed in STAD for RNA.
This table ranks reproducible tumor–normal expression differences for TUBB7P. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. TUBB7P shows lower tumor expression in THCA and KIRC and higher tumor expression in STAD, LIHC, UCEC and BRCA. The STAD box plot shows higher TUBB7P RNA expression in tumor versus normal tissue (log2 FC = +0.218, t-test p = .005).
This table shows molecular features associated with TUBB7P in patient tissues and cancer cell lines. In patient samples, TUBB7P shows the broadest associations at the RNA and protein expression levels, with TGCT recurring as the lineage with the largest associated feature set. In cancer cell lines, TUBB7P RNA and mutation anchors are most strongly linked to RNA-expression features, especially in NCI60_ALL.
